NCT05290792View on ClinicalTrials.gov

Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Viral Respiratory Tract InfectionInfluenza
Interventions
BIOLOGICAL

Administration of FluMist (Live Attenuated Influenza Vaccine)

Participants will received the intranasal FluMist vaccine that will serve as a proxy for a viral respiratory tract infection and trigger a mild immune response.

Trial Locations (1)

H4A 3J1

Centre for Innovative Medicine - McGill University Health Centre, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Université de Montréal

OTHER

lead

Emily McDonald

OTHER

NCT05290792 - Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections | Biotech Hunter | Biotech Hunter